Placebo 0 mg hard gelatin capsule size 0, (placebo to LNP023), IPTACOPAN
CLNP023Q12301
Phase 3 small_molecule active
Quick answer
Placebo 0 mg hard gelatin capsule size 0, (placebo to LNP023), IPTACOPAN for generalized Myasthenia Gravis is a Phase 3 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- generalized Myasthenia Gravis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active